Pseudomonas aeruginosa clinical trials
How each study uses Pseudomonas aeruginosa is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Pseudomonas aeruginosa studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Pseudomonas aeruginosa
- 2
Studies by the year they started
3 studies that test it; most in 2011 (1)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2023 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 3
Fudan University (1) · Jianyi Li (1) · Qilu Hospital of Shandong University (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Pseudomonas aeruginosa is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Pseudomonas Aeruginosa Injection Combined With Polyvinylpyrrolidone-Iodine in Immediate Breast Reconstruction Surgery With ImplantsEnrolling by invitationNot applicableJianyi LiNCT07460297Written as Pseudomonas aeruginosa
- Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder CancerRecruitingPhase 2Qilu Hospital of Shandong UniversityNCT05975151Written as Pseudomonas aeruginosa
- Capecitabine and Pseudomonas Aeruginosa Combination in Metastatic Breast Cancer (MBC)CompletedPhase 2Fudan UniversityNCT01380808Written as capecitabine and pseudomonas aeruginosa combination
Codes
What other systems call Pseudomonas aeruginosa · ClinicalTrials.gg INT018560
- UNII (FDA) Y793W5V55NPSEUDOMONAS AERUGINOSAConfirmed FDA, Wikidata
- RxNorm 1310913One source FDA
- Wikidata Q31856Pseudomonas aeruginosaConfirmed FDA, Wikidata
- NCI Thesaurus C86696Pseudomonas aeruginosaOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | Y793W5V55N | PSEUDOMONAS AERUGINOSA | Confirmed FDA, Wikidata |
| RxNorm | 1310913 | — | One source FDA |
| Wikidata | Q31856 | Pseudomonas aeruginosa | Confirmed FDA, Wikidata |
| NCI Thesaurus | C86696 | Pseudomonas aeruginosa | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.